Copyright © 2006, European Society of Cardiology
Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling
aDepartment of Cardiothoracic Surgery, Carlyle Fraser Heart Centre/Crawford Long Hospital, Emory University School of Medicine, Atlanta, GA 30308-2225, United States
bDepartment of Physiology, Brody School of Medicine, East Carolina University, Greenville, NC 27858-4353, United States
* Corresponding author. Cardiothoracic Research Laboratory, Crawford Long Hospital 550 Peachtree Street, NE, Atlanta, GA 30308-2225, United States. Tel.: +1 404 686 2511; fax: +1 404 686 4888. Email address: azatta{at}emory.edu
Objective Using non-selective and selective protein kinase C (PKC)
and
isoform inhibitors, we tested the hypothesis that the cardioprotective phenotype invoked by postconditioning (postcon) is dependent on PKC signalling. Furthermore, we determined whether postconditioning alters pPKC
and/or pPKC
in cytosolic and mitochondrial fractions.
Methods Male Sprague–Dawley rats underwent 30 min left coronary artery (LCA) occlusion followed by 3 h of reperfusion. Rats were randomised to the following groups: Untreated, no intervention either before or after LCA occlusion; Postcon, 3 cycles of 10-s full reperfusion and 10-s re-occlusion, initiated immediately at the onset of reperfusion; Chelerythrine (non-selective PKC inhibitor, 5 mg/kg)±postcon; Rottlerin (PKC
inhibitor, 0.3 mg/kg)±postcon; KIE1-1 (PKC
inhibitor, 3.8 mg/kg)± postcon. A subset of rats was employed to assess pPKC
and/or pPKC
in sham, Isch/RP (30-min LCA occlusion followed by 30-min reperfusion), and postcon-treated hearts.
Results Infarct size, expressed as area of necrosis as a percentage of the area at risk, AN/AAR (%), was significantly reduced by postcon compared to control (untreated) rats (39±2% vs. 53±1% in control, P<0.001). Treatment with chelerythrine alone or the PKC
antagonist KIE1-1 alone at reperfusion had no effect on infarct size compared to control. In contrast, the infarct-sparing effect of postcon was abrogated by non-selective PKC inhibition and PKC
antagonism (50±2% and 50±1%, respectively, P<0.002). Inhibition of PKC
reduced infarct size to values comparable to that in postcon group (36±3% vs. 39±2%). However, postcon in the presence of PKC
inhibitor did not enhance the infarct-sparing effects (38±2%). In addition, pPKC
in postcon hearts was significantly higher in the total cell homogenate (10338±1627 vs. 4165±608 in Isch/RP, arbitrary units), and pPKC
translocation to mitochondria was significantly less (>2-fold decrease) compared to Isch/RP.
Conclusion These data suggest that postcon modulates PKC during early reperfusion by increasing PKC
expression and translocation to a site other than the outer mitochondrial membrane, and limits translocation of PKC
to mitochondria and associated deleterious signalling.
KEYWORDS Postconditioning; Myocardial infarction; Mitochondria; Protein kinase C; Protein phosphorylation; Reperfusion injury
Time for primary review 25 days
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. J. Hausenloy and D. M. Yellon Cardioprotective growth factors Cardiovasc Res, July 15, 2009; 83(2): 179 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Couvreur, R. Tissier, S. Pons, M. Chenoune, X. Waintraub, A. Berdeaux, and B. Ghaleh The Ceiling Effect of Pharmacological Postconditioning with the Phytoestrogen Genistein Is Reversed by the GSK3{beta} Inhibitor SB 216763 [3-(2,4-Dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione] through Mitochondrial ATP-Dependent Potassium Channel Opening J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 1134 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kuno, N. V. Solenkova, V. Solodushko, T. Dost, Y. Liu, X.-M. Yang, M. V. Cohen, and J. M. Downey Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1288 - H1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. C. Yong, S. W. Lee, C. S. Foo, K. L. Neo, X. Chen, and J.-S. Bian Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1330 - H1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Murphy and C. Steenbergen Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury Physiol Rev, April 1, 2008; 88(2): 581 - 609. [Abstract] [Full Text] [PDF] |
||||



